Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Miji International Holdings Limited ( (HK:1715) ) has shared an update.
AI Health Technology Limited has scheduled a board meeting for 31 March 2026 to approve the audited annual results for the year ended 31 December 2025. The board will also consider the recommendation of a final dividend, a decision that could affect shareholder returns and signal management’s confidence in the company’s financial performance.
The announcement confirms the current composition of the board, led by chairman and executive director Zhao Jie alongside other executive and independent non-executive directors. This disclosure underscores the company’s adherence to corporate governance practices and keeps investors informed ahead of the forthcoming results and potential dividend decision.
The most recent analyst rating on (HK:1715) stock is a Hold with a HK$0.48 price target. To see the full list of analyst forecasts on Miji International Holdings Limited stock, see the HK:1715 Stock Forecast page.
More about Miji International Holdings Limited
AI Health Technology Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange under stock code 1715. The company operates in the health technology sector and is governed by a board comprising executive and independent non-executive directors based in Hong Kong and mainland China, reflecting a regional focus within the broader healthcare and technology markets.
Average Trading Volume: 640,604
Technical Sentiment Signal: Hold
Current Market Cap: HK$147.9M
Find detailed analytics on 1715 stock on TipRanks’ Stock Analysis page.